Liver Cancer Cell Lines
Database

LCCL to predict drug response

Drug: Sorafenib

DrugsAliasTargetsTargeted cellular functionClinical status in any tumor typeClinical status in HCCSupplierReference
Sorafenib BAY 43-9006 BRAF, KDR, FLT4, PDGFRB, KIT, FLT3, RET Tyrosine kinases Approved Approved Selleck Chemicals S1040

Cell Line (34)
Cell LineAUCGI50
B10.781.35
JHH50.821.9
Li70.841.845
HCC.1.20.866.467
HLE0.863.65
HepG20.872.5
HCC.30.95.433
SNU3540.913.027
SNU3980.915.115
JHH70.914.16
Huh60.914.826
SNU1820.929.245
SNU3680.927.532
Hep3B0.936.333
SNU4490.946.768


LCCL transcriptomic subgroup:
CL1
CL2
CL3
undef.

Codebase Soc. Coop.
info@codebase.it